Cargando…
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community
Pharmacovigilance, the science and practice of monitoring the effects of medicinals and their safety, is the responsibility of all stakeholders involved in the development, manufacture, regulation, distribution, prescription, and use of drugs and devices. The patient is the stakeholder most impacted...
Autores principales: | Robinson, Fiona, Wilkes, Sonji, Schaefer, Nathan, Goldstein, Miriam, Rice, Michelle, Gray, Johanna, Meyers, Sharon, Valentino, Leonard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969430/ https://www.ncbi.nlm.nih.gov/pubmed/36861041 http://dx.doi.org/10.1177/20420986221146418 |
Ejemplares similares
-
The MHRA pharmacovigilance inspection programme: priorities and
challenges
por: Adams, Anna L, et al.
Publicado: (2019) -
Defining the Impact of Social Drivers on Health Outcomes for People with Inherited Bleeding Disorders
por: Lopez, Karina, et al.
Publicado: (2022) -
Pharmacovigilance in Israel – tools, processes, and actions
por: Schwartzberg, Eyal, et al.
Publicado: (2017) -
Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
por: Bakare, Nyasha, et al.
Publicado: (2011) -
Building the blueprint: Formulating a community‐generated national plan for future research in inherited bleeding disorders
por: Valentino, Leonard A., et al.
Publicado: (2022)